Temozolomide-associated organizing pneumonitis

Fabien Maldonado, Andrew Harold Limper, Kaiser G. Lim, Marie Christine Aubry

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Temozolomide is an oral alkylating agent recently approved for the treatment of glioblastoma multiforme. It has a favorable side effect profile and is generally well tolerated. Although mild respiratory symptoms have been described, pulmonary toxicity that requires discontinuation of therapy is rare. To our knowledge, this is the first case of temozolomide-associated organizing pneumonitis.

Original languageEnglish (US)
Pages (from-to)771-773
Number of pages3
JournalMayo Clinic Proceedings
Volume82
Issue number6
DOIs
StatePublished - 2007

Fingerprint

temozolomide
Pneumonia
Alkylating Agents
Glioblastoma
Lung
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Temozolomide-associated organizing pneumonitis. / Maldonado, Fabien; Limper, Andrew Harold; Lim, Kaiser G.; Aubry, Marie Christine.

In: Mayo Clinic Proceedings, Vol. 82, No. 6, 2007, p. 771-773.

Research output: Contribution to journalArticle

Maldonado, Fabien ; Limper, Andrew Harold ; Lim, Kaiser G. ; Aubry, Marie Christine. / Temozolomide-associated organizing pneumonitis. In: Mayo Clinic Proceedings. 2007 ; Vol. 82, No. 6. pp. 771-773.
@article{9525d0d7b53e4ab096fb26f8f84539e0,
title = "Temozolomide-associated organizing pneumonitis",
abstract = "Temozolomide is an oral alkylating agent recently approved for the treatment of glioblastoma multiforme. It has a favorable side effect profile and is generally well tolerated. Although mild respiratory symptoms have been described, pulmonary toxicity that requires discontinuation of therapy is rare. To our knowledge, this is the first case of temozolomide-associated organizing pneumonitis.",
author = "Fabien Maldonado and Limper, {Andrew Harold} and Lim, {Kaiser G.} and Aubry, {Marie Christine}",
year = "2007",
doi = "10.4065/82.6.771",
language = "English (US)",
volume = "82",
pages = "771--773",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "6",

}

TY - JOUR

T1 - Temozolomide-associated organizing pneumonitis

AU - Maldonado, Fabien

AU - Limper, Andrew Harold

AU - Lim, Kaiser G.

AU - Aubry, Marie Christine

PY - 2007

Y1 - 2007

N2 - Temozolomide is an oral alkylating agent recently approved for the treatment of glioblastoma multiforme. It has a favorable side effect profile and is generally well tolerated. Although mild respiratory symptoms have been described, pulmonary toxicity that requires discontinuation of therapy is rare. To our knowledge, this is the first case of temozolomide-associated organizing pneumonitis.

AB - Temozolomide is an oral alkylating agent recently approved for the treatment of glioblastoma multiforme. It has a favorable side effect profile and is generally well tolerated. Although mild respiratory symptoms have been described, pulmonary toxicity that requires discontinuation of therapy is rare. To our knowledge, this is the first case of temozolomide-associated organizing pneumonitis.

UR - http://www.scopus.com/inward/record.url?scp=34249930493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249930493&partnerID=8YFLogxK

U2 - 10.4065/82.6.771

DO - 10.4065/82.6.771

M3 - Article

VL - 82

SP - 771

EP - 773

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 6

ER -